Related Experiment Video
Updated: Jun 24, 2026
09:01
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
cDNA microarray analysis of inflammatory breast cancer signatures
Steven J Van Laere1, Peter B Vermeulen, Luc Y Dirix
1Translational Cancer Research Group, Lab Pathology, University of Antwerp, Oncology Center, General Hospital Sint-Augustinus, Wilrijk, Belgium.
Methods in Molecular Biology (Clifton, N.J.)
|April 7, 2009
Summary
Inflammatory breast cancer (IBC) has a unique gene expression profile distinct from other breast cancer subtypes. This molecular signature reveals potential therapeutic targets like NF-kappaB for aggressive IBC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Molecular profiling identifies breast cancer subtypes with distinct prognoses and therapeutic responses.
- Inflammatory breast cancer (IBC) is an aggressive form of locally advanced breast cancer.
Purpose of the Study:
- To investigate the gene expression profile of inflammatory breast cancer (IBC).
- To identify novel therapeutic targets for IBC based on its unique molecular signature.
Main Methods:
- Utilized cDNA microarrays for global gene expression profiling of IBC samples.
- Analyzed gene expression patterns to identify distinct molecular characteristics of IBC.
Main Results:
- IBC exhibits a unique gene expression profile, separate from previously identified breast cancer subtypes.
- Identified the transcription factor NF-kappaB as a potential therapeutic target in IBC.
Conclusions:
- Gene expression profiling is crucial for understanding IBC's distinct biology.
- The identified molecular targets, such as NF-kappaB, offer new avenues for IBC therapy.
